← Back to Search

Procedure

Oocytes allocated to the box incubator for Infertility (VILOCITY Trial)

Q: Do I meet the necessary criteria to be considered as a potential candidate for involvement in this medical study?

In order to be considered for participation in this clinical trial, patients must meet the eligibility criteria of being between 18 and 41 years old and experiencing <a href="https://www.withpower.com/clinical-trials/infertility">infertility</a>. The study aims to enroll approximately 252 individuals.

Q: Are individuals currently able to apply and participate in this ongoing clinical trial?

Based on the current information available on clinicaltrials.gov, this trial is currently accepting applicants. The study was initially posted on December 19, 2023 and underwent its most recent update on January 16, 2024.

Q: What is the overall count of participants involved in this clinical investigation?

Indeed, as per the details on clinicaltrials.gov, this ongoing clinical trial is actively seeking individuals to participate. The trial was initially posted on December 19th, 2023 and most recently updated on January 16th, 2024. A total of 252 participants are being sought from a single location.

Q: Is the age eligibility criteria for this trial limited to individuals below 60 years old?

This clinical trial is seeking individuals aged 18 years or older but below the age of 41 to participate in the study.

N/A

Recruiting

Led By Thomas Molinaro, MD, MSCE

Research Sponsored by Reproductive Medicine Associates of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Normal ovarian reserve: Antimullerian Hormone Level (AMH) ≥ 1.2 ng/mL, Antral Follicle Count (AFC) ≥ 8, Follicle Stimulating Hormone (FSH) FSH ≤ 12 international units (IU)/L, Body Mass Index (BMI) <35

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 7 months after discharge to obstetrician

Awards & highlights

VILOCITY Trial Summary

This trial aims to determine if using a specific type of incubator can improve the number of embryos that reach the blastocyst stage during in vitro fertilization (IVF) treatment. The study will

Who is the study for?

This trial is for people undergoing IVF treatment due to infertility. Participants will have their mature oocytes collected and randomly assigned to two groups, each using a different type of incubator (benchtop or box) to culture the embryos.Check my eligibility

What is being tested?

The study aims to compare benchtop and box incubators in terms of improving the number of embryos reaching blastocyst stage during IVF. It also looks at embryology outcomes, transfer success, and pregnancy rates between the two methods.See study design

What are the potential side effects?

Since this trial involves standard IVF procedures with different types of incubators rather than drugs or invasive treatments, there are no additional side effects beyond those typically associated with IVF.

VILOCITY Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My fertility tests are normal and my BMI is under 35.

VILOCITY Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 7 months after discharge to obstetrician

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 7 months after discharge to obstetrician

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 7 months after discharge to obstetrician for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blastulation Rate per mature oocyte (M2)

Secondary outcome measures

Blastocyst Morphology using Modified Gardner Scale

Blastulation Rate per 2PN

Embryologist Questionnaire

+4 more

VILOCITY Trial Design

2Treatment groups

Experimental Treatment

Group I: Oocytes allocated to the box incubatorExperimental Treatment1 Intervention

Half of the mature oocytes and subsequent embryos will be cultured in the box incubator

Group II: Oocytes allocated to the benchtop incubatorExperimental Treatment1 Intervention

Half of the mature oocytes and subsequent embryos will be cultured in the benchtop incubator

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Reproductive Medicine Associates of New JerseyLead Sponsor

52 Previous Clinical Trials

37,582 Total Patients Enrolled

30 Trials studying Infertility

19,041 Patients Enrolled for Infertility

CooperSurgical Inc.Industry Sponsor

3 Previous Clinical Trials

401 Total Patients Enrolled

Thomas Molinaro, MD, MSCEPrincipal InvestigatorReproductive Medicine Associates of New Jersey

2 Previous Clinical Trials

15,000 Total Patients Enrolled

1 Trials studying Infertility

10,000 Patients Enrolled for Infertility

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to be considered as a potential candidate for involvement in this medical study?

"In order to be considered for participation in this clinical trial, patients must meet the eligibility criteria of being between 18 and 41 years old and experiencing infertility. The study aims to enroll approximately 252 individuals."

Answered by AI

Are individuals currently able to apply and participate in this ongoing clinical trial?

"Based on the current information available on clinicaltrials.gov, this trial is currently accepting applicants. The study was initially posted on December 19, 2023 and underwent its most recent update on January 16, 2024."

Answered by AI

What is the overall count of participants involved in this clinical investigation?

"Indeed, as per the details on clinicaltrials.gov, this ongoing clinical trial is actively seeking individuals to participate. The trial was initially posted on December 19th, 2023 and most recently updated on January 16th, 2024. A total of 252 participants are being sought from a single location."

Answered by AI